1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ORC1 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA BCL2L1 CTRPv2 pan-cancer AAC -0.17 6e-07
mRNA NUFIP1 CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA GRAMD3 CTRPv2 pan-cancer AAC -0.17 7e-07
mRNA KLRG2 CTRPv2 pan-cancer AAC -0.16 7e-07
mRNA ARHGEF17 CTRPv2 pan-cancer AAC -0.17 8e-07
mRNA SRSF7 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA MEGF6 CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA RFXAP CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA MFNG CTRPv2 pan-cancer AAC 0.23 1e-06
Download CSV